Literature DB >> 23178053

Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]).

Rakesh K Mishra1, Yongmei Li, Ana C Ricardo, Wei Yang, Martin Keane, Magdalena Cuevas, Robert Christenson, Christopher deFilippi, Jing Chen, Jiang He, Radhakrishna R Kallem, Dominic S Raj, Jeffrey R Schelling, Jackson Wright, Alan S Go, Michael G Shlipak.   

Abstract

We evaluated the cross-sectional associations of N-terminal pro-B-type natriuretic peptide (NT-proBNP) with cardiac structural and functional abnormalities in a cohort of patients with chronic kidney disease without clinical heart failure, the Chronic Renal Insufficiency Cohort (n = 3,232). The associations of NT-proBNP with echocardiographically determined left ventricular (LV) mass and LV systolic and diastolic function were evaluated using multivariate logistic and linear regression models. Reclassification of participants' predicted risk of LV hypertrophy (LVH), systolic and diastolic dysfunction was performed using a category-free net reclassification improvement index that compared a clinical model with and without NT-proBNP. The median NT-proBNP was 126.6 pg/ml (interquartile range 55.5 to 303.7). The greatest quartile of NT-proBNP was associated with a nearly threefold odds of LVH (odds ratio 2.7, 95% confidence interval [CI] 1.8 to 4.0) and LV systolic dysfunction (odds ratio 2.7, 95% CI 1.7 to 4.5) and a twofold odds of diastolic dysfunction (odds ratio 2.0, 95% CI 1.3 to 2.9) in the fully adjusted models. When evaluated alone as a screening test, NT-proBNP functioned modestly for the detection of LVH (area under the curve 0.66) and LV systolic dysfunction (area under the curve 0.62) and poorly for the detection of diastolic dysfunction (area under the curve 0.51). However, when added to the clinical model, NT-proBNP significantly reclassified participants' likelihood of having LVH (net reclassification improvement 0.14, 95% CI 0.13-0.15; p <0.001) and LV systolic dysfunction (net reclassification improvement 0.28, 95% CI 0.27 to 0.30; p <0.001) but not diastolic dysfunction (net reclassification improvement 0.10, 95% CI 0.10 to 0.11; p = 0.07). In conclusion, in this large chronic kidney disease cohort without heart failure, NT-proBNP had strong associations with prevalent LVH and LV systolic dysfunction.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23178053      PMCID: PMC5261861          DOI: 10.1016/j.amjcard.2012.10.019

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  28 in total

Review 1.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelista
Journal:  J Am Soc Echocardiogr       Date:  2009-02       Impact factor: 5.251

2.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ewout W Steyerberg
Journal:  Stat Med       Date:  2010-11-05       Impact factor: 2.373

3.  Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients.

Authors:  Carmine Zoccali; Francesca Mallamaci; Francesco Antonio Benedetto; Giovanni Tripepi; Saverio Parlongo; Alessandro Cataliotti; Sebastiano Cutrupi; Giuseppe Giacone; Ignazio Bellanuova; Emilio Cottini; Lorenzo Salvatore Malatino
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

4.  N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.

Authors:  Ijaz A Khan; Jeffrey Fink; Caitlin Nass; Hegang Chen; Robert Christenson; Christopher R deFilippi
Journal:  Am J Cardiol       Date:  2006-03-31       Impact factor: 2.778

Review 5.  Statistical methods for assessment of added usefulness of new biomarkers.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Clin Chem Lab Med       Date:  2010-08-18       Impact factor: 3.694

6.  Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk.

Authors:  G de Simone; R B Devereux; S R Daniels; M J Koren; R A Meyer; J H Laragh
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094

7.  Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients.

Authors:  Sangeetha Satyan; Robert P Light; Rajiv Agarwal
Journal:  Am J Kidney Dis       Date:  2007-12       Impact factor: 8.860

8.  Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

Authors:  H Yasue; M Yoshimura; H Sumida; K Kikuta; K Kugiyama; M Jougasaki; H Ogawa; K Okumura; M Mukoyama; K Nakao
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

9.  Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).

Authors:  A Bergström; B Andersson; M Edner; E Nylander; H Persson; U Dahlström
Journal:  Eur J Heart Fail       Date:  2004-06       Impact factor: 15.534

10.  Impact of left ventricular end-diastolic wall stress on plasma B-type natriuretic peptide in heart failure with chronic kidney disease and end-stage renal disease.

Authors:  Shinichiro Niizuma; Yoshitaka Iwanaga; Takaharu Yahata; Yodo Tamaki; Yoichi Goto; Hajime Nakahama; Shunichi Miyazaki
Journal:  Clin Chem       Date:  2009-05-21       Impact factor: 8.327

View more
  28 in total

1.  Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort.

Authors:  Faraz S Ahmad; Xuan Cai; Katherine Kunkel; Ana C Ricardo; James P Lash; Dominic S Raj; Jiang He; Amanda H Anderson; Matthew J Budoff; Julie A Wright Nunes; Jason Roy; Jackson T Wright; Alan S Go; Martin G St John Sutton; John W Kusek; Tamara Isakova; Myles Wolf; Martin G Keane
Journal:  Am J Hypertens       Date:  2017-08-01       Impact factor: 2.689

Review 2.  Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD.

Authors:  Gates Colbert; Nishank Jain; James A de Lemos; S Susan Hedayati
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-17       Impact factor: 8.237

3.  High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Nisha Bansal; Amanda Hyre Anderson; Wei Yang; Robert H Christenson; Christopher R deFilippi; Rajat Deo; Daniel L Dries; Alan S Go; Jiang He; John W Kusek; James P Lash; Dominic Raj; Sylvia Rosas; Myles Wolf; Xiaoming Zhang; Michael G Shlipak; Harold I Feldman
Journal:  J Am Soc Nephrol       Date:  2014-10-02       Impact factor: 10.121

4.  Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study.

Authors:  Meyeon Park; Eric Vittinghoff; Michael G Shlipak; Rakesh Mishra; Mary Whooley; Nisha Bansal
Journal:  Am Heart J       Date:  2014-10-14       Impact factor: 4.749

5.  Relation of N-terminal pro-B-type natriuretic peptide with diastolic function in hypertensive heart disease.

Authors:  Imran Uraizee; Susan Cheng; Chung-Lieh Hung; Anil Verma; James D Thomas; Michael R Zile; Gerard P Aurigemma; Scott D Solomon
Journal:  Am J Hypertens       Date:  2013-06-22       Impact factor: 2.689

6.  Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study.

Authors:  Rakesh K Mishra; Wei Yang; Jason Roy; Amanda H Anderson; Nisha Bansal; Jing Chen; Christopher DeFilippi; Patrice Delafontaine; Harold I Feldman; Radhakrishna Kallem; John W Kusek; Claudia M Lora; Sylvia E Rosas; Alan S Go; Michael G Shlipak
Journal:  Circ Heart Fail       Date:  2015-05-18       Impact factor: 8.790

7.  NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.

Authors:  Nisha Bansal; Ronit Katz; Lorien Dalrymple; Ian de Boer; Christopher DeFilippi; Bryan Kestenbaum; Meyeon Park; Mark Sarnak; Stephen Seliger; Michael Shlipak
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-20       Impact factor: 8.237

8.  Evaluation of left atrial remodeling in kidney transplant patients using cardiac magnetic resonance imaging.

Authors:  Flora Huang; Philip W Connelly; G V Ramesh Prasad; Michelle M Nash; Lakshman Gunaratnam; Djeven P Deva; Charmaine E Lok; Weiqiu Yuan; Rachel M Wald; Tamar Shalmon; Ron Wald; Kim A Connelly; Andrew T Yan
Journal:  J Nephrol       Date:  2020-09-10       Impact factor: 3.902

9.  NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4.

Authors:  Kathrin Untersteller; Nicolas Girerd; Kevin Duarte; Kyrill S Rogacev; Sarah Seiler-Mussler; Danilo Fliser; Patrick Rossignol; Gunnar H Heine
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-11       Impact factor: 8.237

10.  Estimated Glomerular Filtration Rate, Activation of Cardiac Biomarkers and Long-Term Cardiovascular Outcomes: A Population-Based Cohort.

Authors:  Shravya Vinnakota; Christopher G Scott; Richard J Rodeheffer; Horng H Chen
Journal:  Mayo Clin Proc       Date:  2019-10-23       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.